118 related articles for article (PubMed ID: 8385567)
21. Establishment and characterization of malignant rhabdoid tumor of the kidney.
Kinoshita Y; Tamiya S; Oda Y; Mimori K; Inoue H; Ohta S; Tajiri T; Suita S; Tsuneyoshi M
Oncol Rep; 2001; 8(1):43-8. PubMed ID: 11115567
[TBL] [Abstract][Full Text] [Related]
22. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
Pawel BR
Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
[TBL] [Abstract][Full Text] [Related]
23. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16.
Kuroda H; Moritake H; Sawada K; Kuwahara Y; Imoto I; Inazawa J; Sugimoto T
Cancer Genet Cytogenet; 2005 Apr; 158(2):172-9. PubMed ID: 15796965
[TBL] [Abstract][Full Text] [Related]
24. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic?
Fuller CE; Pfeifer J; Humphrey P; Bruch LA; Dehner LP; Perry A
Hum Pathol; 2001 Oct; 32(10):1102-8. PubMed ID: 11679945
[TBL] [Abstract][Full Text] [Related]
25. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features.
Oda Y; Tsuneyoshi M
Pathol Int; 2006 Jun; 56(6):287-95. PubMed ID: 16704491
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of human cytokeratin 8 gene in malignant rhabdoid tumor: a possible association with intracytoplasmic inclusion body formation.
Shiratsuchi H; Saito T; Sakamoto A; Itakura E; Tamiya S; Oshiro Y; Oda Y; Toh S; Komiyama S; Tsuneyoshi M
Mod Pathol; 2002 Feb; 15(2):146-53. PubMed ID: 11850543
[TBL] [Abstract][Full Text] [Related]
27. Cytokeratin subunits of inclusion bodies in rhabdoid cells: immunohistochemical and clinicopathological study of malignant rhabdoid tumor and epithelioid sarcoma.
Shiratsuchi H; Oshiro Y; Saito T; Itakura E; Kinoshita Y; Tamiya S; Oda Y; Komiyama S; Tsuneyoshi M
Int J Surg Pathol; 2001 Jan; 9(1):37-48. PubMed ID: 11469343
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of a human primitive neuroectodermal tumor cell line from the cerebral hemisphere.
Fults D; Pedone CA; Morse HG; Rose JW; McKay RD
J Neuropathol Exp Neurol; 1992 May; 51(3):272-80. PubMed ID: 1316433
[TBL] [Abstract][Full Text] [Related]
29. Rhabdoid tumor of the kidney is a component of the rhabdoid predisposition syndrome.
Lee HY; Yoon CS; Sevenet N; Rajalingam V; Delattre O; Walford NQ
Pediatr Dev Pathol; 2002; 5(4):395-9. PubMed ID: 12016529
[TBL] [Abstract][Full Text] [Related]
30. Primitive neuroectodermal tumor of the brain associated with malignant rhabdoid tumor of the liver: a histologic, immunohistochemical, and electron microscopic study.
Chang CH; Ramirez N; Sakr WA
Pediatr Pathol; 1989; 9(3):307-19. PubMed ID: 2546137
[TBL] [Abstract][Full Text] [Related]
31. Primitive neuroectodermal tumor cell lines: chromosomal analysis of five cases.
Potluri VR; Gilbert F; Helsen C; Helson L
Cancer Genet Cytogenet; 1987 Jan; 24(1):75-86. PubMed ID: 3024811
[TBL] [Abstract][Full Text] [Related]
32. Soft tissue Ewing's sarcoma. Characterization in established cultures and xenografts with evidence of a neuroectodermic phenotype.
Llombart-Bosch A; Carda C; Peydro-Olaya A; Noguera R; Perez-Bacete M; Pellin A; Boix J
Cancer; 1990 Dec; 66(12):2589-601. PubMed ID: 1701108
[TBL] [Abstract][Full Text] [Related]
33. Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.
Vujanić GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
Am J Surg Pathol; 2007 Oct; 31(10):1459-68. PubMed ID: 17895746
[TBL] [Abstract][Full Text] [Related]
34. Malignant rhabdoid tumor in the renal allograft of an adult transplant recipient: a unique case of a rare tumor.
Xiong J; Su T; Zhu P; Ao Q; Ruan Q; Wang G
Diagn Pathol; 2017 Dec; 12(1):86. PubMed ID: 29258531
[TBL] [Abstract][Full Text] [Related]
35. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
Roberts DJ; Haber D; Sklar J; Crum CP
Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
[TBL] [Abstract][Full Text] [Related]
36. CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor.
Nodomi S; Umeda K; Saida S; Kinehara T; Hamabata T; Daifu T; Kato I; Hiramatsu H; Watanabe KI; Kuwahara Y; Iehara T; Adachi S; Konishi E; Nakahata T; Hosoi H; Heike T
Oncogene; 2016 Oct; 35(40):5317-5327. PubMed ID: 27041577
[TBL] [Abstract][Full Text] [Related]
37. Dynamic model of differentiation in Ewing's sarcoma cells. Comparative analysis of morphologic, immunocytochemical, and oncogene expression parameters.
Noguera R; Triche TJ; Navarro S; Tsokos M; Llombart-Bosch A
Lab Invest; 1992 Feb; 66(2):143-51. PubMed ID: 1310513
[TBL] [Abstract][Full Text] [Related]
38. Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion.
Wick MR; Ritter JH; Dehner LP
Semin Diagn Pathol; 1995 Aug; 12(3):233-48. PubMed ID: 8545590
[TBL] [Abstract][Full Text] [Related]
39. The association of embryonal tumors originating in the kidney and in the brain. A report of seven cases.
Bonnin JM; Rubinstein LJ; Palmer NF; Beckwith JB
Cancer; 1984 Nov; 54(10):2137-46. PubMed ID: 6091860
[TBL] [Abstract][Full Text] [Related]
40. Primary CNS malignant rhabdoid tumor (MRT): report of two cases and review of literature.
Chou SM; Anderson JS
Clin Neuropathol; 1991; 10(1):1-10. PubMed ID: 2015720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
